AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15809123 — intervention group
Group type: EXPERIMENTAL
Intervention: L-bupivacaine (2.5 mg) + fentanyl (25 microg)
Number of subjects: 67
Study 15809123 — intervention group
Group type: COMPARATOR
Intervention: Racemic bupivacaine and L-bupivacaine
Number of subjects: 67
Study 12114402 — intervention group
Group type: EXPERIMENTAL
Intervention: CTP37-DT vaccine administered intramuscularly on days 0, 28, and 70.
Number of subjects: 77
Study 12114402 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified in the abstract.
Number of subjects: 77
Study 10665017 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal goals
Number of subjects: 40
Study 10665017 — intervention group
Group type: EXPERIMENTAL
Intervention: Difficult assigned goals
Number of subjects: 40
Study 10665017 — intervention group
Group type: EXPERIMENTAL
Intervention: Easy assigned goals
Number of subjects: 40
Study 10665017 — intervention group
Group type: COMPARATOR
Intervention: No goals
Number of subjects: 40
Study 7553242 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymetazoline nasal spray with benzalkonium chloride
Number of subjects: 20
Study 7553242 — intervention group
Group type: COMPARATOR
Intervention: Oxymetazoline nasal spray alone
Number of subjects: 20
Study 2081899 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5 mg)
Number of subjects: 36
Study 2081899 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurazepam (30 mg)
Number of subjects: 36
Study 2081899 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 274263 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% SnF2 solution
Number of subjects: 0
Study 274263 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% SnF2 solution
Number of subjects: 0
Study 274263 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 0
Study 30989175 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antibiotic therapy
Number of subjects: 0
Study 30989175 — intervention group
Group type: COMPARATOR
Intervention: Prolonged intravenous therapy
Number of subjects: 0
Study 29336753 — intervention group
Group type: EXPERIMENTAL
Intervention: Lightweight mesh
Number of subjects: 67
Study 29336753 — intervention group
Group type: COMPARATOR
Intervention: Heavyweight mesh
Number of subjects: 67
Study 25536008 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (140 mL, providing 12.9 mmol of nitrate)
Number of subjects: 12
Study 25536008 — intervention group
Group type: COMPARATOR
Intervention: Placebo (nitrate-depleted Beet-It Sport)
Number of subjects: 12
Study 23827657 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural Activation for Worry (BAW)
Number of subjects: 49
Study 23827657 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 49
Study 21980205 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 2502
Study 21980205 — intervention group
Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 2502
Study 21980205 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke events
Number of subjects: 2502
Study 19788968 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of active second-stage labor (1 hour)
Number of subjects: 1862
Study 19788968 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of active second-stage labor (2 hours)
Number of subjects: 1862
Study 19788968 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of active second-stage labor (>3 hours)
Number of subjects: 1862
Study 19788968 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of pushing (after 2 hours)
Number of subjects: 1862
Study 16448575 — intervention group
Group type: EXPERIMENTAL
Intervention: Primaquine (PQ) 45 mg
Number of subjects: 90
Study 16448575 — intervention group
Group type: COMPARATOR
Intervention: Bulaquine (BQ) 75 mg
Number of subjects: 90
Study 15561834 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate exposure during the previous 3 months
Number of subjects: 648
Study 11783028 — intervention group
Group type: EXPERIMENTAL
Intervention: CCNU or BCNU after 20-40 Gy irradiation to the brain
Number of subjects: 56
Study 11783028 — intervention group
Group type: COMPARATOR
Intervention: Radiation treatment alone
Number of subjects: 56
Study 9778203 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine besylate (5 mg/d)
Number of subjects: 192
Study 9778203 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine coat core (30 mg/d)
Number of subjects: 192
Study 9778203 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine gastrointestinal therapeutic system (GITS) (30 mg/d)
Number of subjects: 192
Study 9778203 — intervention group
Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 192
Study 7937860 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-induced fluorescence at 337-nm excitation
Number of subjects: 28
Study 2455114 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 22
Study 2455114 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactive hyperemia after arterial occlusion combined with handgrip exercise and local heating
Number of subjects: 22
Study 2455114 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterial occlusion combined with nifedipine
Number of subjects: 22
Study 31077519 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized Occupational Therapy (IOT)
Number of subjects: 111
Study 31077519 — intervention group
Group type: COMPARATOR
Intervention: Group Occupational Therapy (GOT) alone
Number of subjects: 111
Study 31077519 — intervention group
Group type: EXPERIMENTAL
Intervention: GOT + IOT
Number of subjects: 111
Study 31077519 — intervention group
Group type: COMPARATOR
Intervention: GOT-alone
Number of subjects: 111
Study 31077519 — intervention group
Group type: EXPERIMENTAL
Intervention: Type of occupational therapy
Number of subjects: 111
Study 31077519 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication adherence
Number of subjects: 111
Study 31077519 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to resident support persons
Number of subjects: 111
Study 31077519 — intervention group
Group type: EXPERIMENTAL
Intervention: Executive function at discharge
Number of subjects: 111
Study 30120445 — intervention group
Group type: EXPERIMENTAL
Intervention: Transitive syntactic frames
Number of subjects: 32
Study 30120445 — intervention group
Group type: COMPARATOR
Intervention: Intransitive syntactic frames
Number of subjects: 32
Study 27535371 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin cream
Number of subjects: 24
Study 27535371 — intervention group
Group type: COMPARATOR
Intervention: Control (inert lotion)
Number of subjects: 24
Study 24777691 — intervention group
Group type: EXPERIMENTAL
Intervention: Colesevelam 1.5-4.5 g/day
Number of subjects: 154
Study 24777691 — intervention group
Group type: EXPERIMENTAL
Intervention: Colesevelam 3.75 g/day
Number of subjects: 154
Study 24777691 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study 22798322 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids with vitamin D deficiency
Number of subjects: 1024
Study 22798322 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids with vitamin D insufficiency
Number of subjects: 1024
Study 22798322 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids with vitamin D sufficiency
Number of subjects: 1024
Study 22798322 — intervention group
Group type: COMPARATOR
Intervention: Inhaled corticosteroids (control group)
Number of subjects: 1024
Study 19969409 — intervention group
Group type: EXPERIMENTAL
Intervention: Oestradiol valerate (E2V) and dienogest (DNG) administered over 20 cycles with a specific dosing schedule: E2V 3 mg on days 1 and 2, E2V 2 mg/DNG 2 mg on days 3-7, E2V 2 mg/DNG 3 mg on days 8-24, E2V 1 mg on days 25 and 26, and placebo on days 27 and 28.
Number of subjects: 1377
Study 19969409 — intervention group
Group type: EXPERIMENTAL
Intervention: Oestradiol valerate (E2V) and dienogest (DNG) in subgroup of women aged 18-35 years (998 participants).
Number of subjects: 1377
Study 17414737 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium levels preceding reappearance of manic or mixed symptomatology
Number of subjects: 86
Study 17414737 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium levels preceding reappearance of depressive symptoms
Number of subjects: 86
Study 17414737 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression analyses
Number of subjects: 86
Study 15457373 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (120 mg/d)
Number of subjects: 20
Study 15457373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 15457373 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 20
Study 15457373 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol
Number of subjects: 20
Study 15457373 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 20
Study 15457373 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-blockers
Number of subjects: 20
Study 15457373 — intervention group
Group type: EXPERIMENTAL
Intervention: Choline (substituting extracellular sodium)
Number of subjects: 20
Study 11145109 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat (40% of daily energy), high-monounsaturated-fat diet
Number of subjects: 12
Study 11145109 — intervention group
Group type: COMPARATOR
Intervention: Low-fat (30% of daily energy) diet
Number of subjects: 12
Study 11145109 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 12
Study 9352757 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV)
Number of subjects: 10
Study 9352757 — intervention group
Group type: COMPARATOR
Intervention: Optimal intermittent positive pressure ventilation (IPPV)
Number of subjects: 10
Study 7654577 — intervention group
Group type: EXPERIMENTAL
Intervention: AC/DC iontophoresis
Number of subjects: 0
Study 7654577 — intervention group
Group type: COMPARATOR
Intervention: Conventional DC method
Number of subjects: 0
Study 7654577 — intervention group
Group type: COMPARATOR
Intervention: AC without DC-offset
Number of subjects: 0
Study 7654577 — intervention group
Group type: EXPERIMENTAL
Intervention: AC with DC-offset
Number of subjects: 0
Study 3741729 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine (DMI)
Number of subjects: 0
Study 3741729 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3596872 — intervention group
Group type: EXPERIMENTAL
Intervention: O-(beta-hydroxyethyl)-rutosides (HR) 3 g/day for 28 days
Number of subjects: 20
Study 3596872 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 31912929 — intervention group
Group type: EXPERIMENTAL
Intervention: EQUIA Forte
Number of subjects: 0
Study 31912929 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 0
Study 31912929 — intervention group
Group type: EXPERIMENTAL
Intervention: Theracal LC
Number of subjects: 0
Study 31912929 — intervention group
Group type: COMPARATOR
Intervention: Other materials
Number of subjects: 0
Study 31087442 — intervention group
Group type: EXPERIMENTAL
Intervention: 22-NAP (22:00 to 00:00)
Number of subjects: 14
Study 31087442 — intervention group
Group type: EXPERIMENTAL
Intervention: 00-NAP (00:00 to 02:00)
Number of subjects: 14
Study 31087442 — intervention group
Group type: EXPERIMENTAL
Intervention: 02-NAP (02:00 to 04:00)
Number of subjects: 14
Study 31087442 — intervention group
Group type: COMPARATOR
Intervention: Control (not explicitly defined)
Number of subjects: 14
Study 29871226 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart-phone application
Number of subjects: 65
Study 29871226 — intervention group
Group type: COMPARATOR
Intervention: Traditional oral health education (Control)
Number of subjects: 65
Study 26039521 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg) + Ezetimibe (10 mg)
Number of subjects: 18144
Study 26039521 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin (40 mg) + Placebo
Number of subjects: 18144
Study 23222038 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive analytic therapy (CAT) - 24 sessions over 10 months
Number of subjects: 78
Study 23222038 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 78
Study 21983067 — intervention group
Group type: COMPARATOR
Intervention: Probiotic intervention (Lactobacillus rhamnosus + Bifidobacterium longum and Lactobacillus paracasei + Bifidobacterium longum) given to mothers 2 months prior to and 2 months after delivery
Number of subjects: 80
Study 21983067 — intervention group
Group type: COMPARATOR
Intervention: Probiotic intervention
Number of subjects: 80
Study 21983067 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal colonization by B. bifidum
Number of subjects: 80
Study 21983067 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal probiotic treatment
Number of subjects: 80
Study 19064829 — intervention group
Group type: EXPERIMENTAL
Intervention: MedDiet + VOO
Number of subjects: 1224
Study 19064829 — intervention group
Group type: EXPERIMENTAL
Intervention: MedDiet + nuts
Number of subjects: 1224
Study 19064829 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 1224
Study 16773068 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV testing in primary cervical screening
Number of subjects: 24510
Study 15317834 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone + ximelagatran
Number of subjects: 26
Study 15317834 — intervention group
Group type: EXPERIMENTAL
Intervention: Ximelagatran + amiodarone
Number of subjects: 26
Study 15317834 — intervention group
Group type: COMPARATOR
Intervention: Ximelagatran
Number of subjects: 26
Study 11020001 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with interferon alpha-2b and ribavirin for 24 weeks
Number of subjects: 428
Study 11020001 — intervention group
Group type: COMPARATOR
Intervention: Interferon alpha-2b monotherapy for 48 weeks
Number of subjects: 428
Study 9279534 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (0.52 mg kg‐1 min‐1)
Number of subjects: 25
Study 8334811 — intervention group
Group type: EXPERIMENTAL
Intervention: Clenbuterol treatment for 4 weeks postoperatively
Number of subjects: 20
Study 8334811 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment for 4 weeks postoperatively
Number of subjects: 20
Study 3595666 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose metoclopramide
Number of subjects: 47
Study 3595666 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose methylprednisolone added to metoclopramide
Number of subjects: 47
Study 3595666 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 47
Study 30066815 — intervention group
Group type: EXPERIMENTAL
Intervention: MARA group
Number of subjects: 120
Study 30066815 — intervention group
Group type: EXPERIMENTAL
Intervention: MARA+SMS group
Number of subjects: 120
Study 30066815 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 30066815 — intervention group
Group type: EXPERIMENTAL
Intervention: MARA group vs MARA+SMS group
Number of subjects: 120
Study 30066815 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiposity measures
Number of subjects: 120
Study 27543277 — intervention group
Group type: EXPERIMENTAL
Intervention: Pakistani almonds (10 g/day)
Number of subjects: 150
Study 27543277 — intervention group
Group type: EXPERIMENTAL
Intervention: American almonds (10 g/day)
Number of subjects: 150
Study 27543277 — intervention group
Group type: COMPARATOR
Intervention: No-intervention (NI)
Number of subjects: 150
Study 26685032 — intervention group
Group type: EXPERIMENTAL
Intervention: Impulsivity-focused group intervention (8 weekly sessions)
Number of subjects: 78
Study 26685032 — intervention group
Group type: COMPARATOR
Intervention: Control group (no group intervention)
Number of subjects: 78
Study 23414589 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with three cycles of TPF followed by concurrent chemoradiotherapy
Number of subjects: 145
Study 23414589 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy alone with two cycles of bolus cisplatin
Number of subjects: 145
Study 23414589 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy followed by chemoradiotherapy
Number of subjects: 145
Study 23414589 — intervention group
Group type: COMPARATOR
Intervention: Chemoradiotherapy alone
Number of subjects: 145
Study 20958842 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 38
Study 20958842 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 18227667 — intervention group
Group type: EXPERIMENTAL
Intervention: Capnography
Number of subjects: 54
Study 18227667 — intervention group
Group type: COMPARATOR
Intervention: Pulse oximetry and respiratory-rate assessment
Number of subjects: 54
Study 16750345 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of DHA daily for 14 days
Number of subjects: 27
Study 16750345 — intervention group
Group type: COMPARATOR
Intervention: 100 mg of olive oil as placebo daily for 14 days
Number of subjects: 27
Study 14659345 — intervention group
Group type: EXPERIMENTAL
Intervention: ROLL intervention using 2 megabecquerels of (99m)Tc-MAA injected directly into the lesion under image guidance.
Number of subjects: 63
Study 10871462 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine cultures
Number of subjects: 391
Study 10871462 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood cultures
Number of subjects: 391
Study 10871462 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic therapy changes
Number of subjects: 391
Study 10871462 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacteremia
Number of subjects: 391
Study 8924099 — intervention group
Group type: EXPERIMENTAL
Intervention: Whirlpool baths (tub group)
Number of subjects: 785
Study 8924099 — intervention group
Group type: COMPARATOR
Intervention: Conventional care (control group)
Number of subjects: 785
Study 8924099 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 785
Study 1396626 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine
Number of subjects: 0
Study 1396626 — intervention group
Group type: COMPARATOR
Intervention: Lignocaine
Number of subjects: 0
Study 3885921 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen inhalation at 6 L/min via nonrebreathing face masks for 15 minutes or less
Number of subjects: 19
Study 3885921 — intervention group
Group type: COMPARATOR
Intervention: Air inhalation at 6 L/min via nonrebreathing face masks for 15 minutes or less
Number of subjects: 19
Study 30863472 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous Pulsed Radiofrequency (TPRF)
Number of subjects: 50
Study 30863472 — intervention group
Group type: COMPARATOR
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 50
Study 30118351 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal therapy
Number of subjects: 100
Study 30118351 — intervention group
Group type: COMPARATOR
Intervention: No periodontal therapy (control)
Number of subjects: 100
Study 26313017 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-Rich Fibrin (PRF)
Number of subjects: 40
Study 26313017 — intervention group
Group type: COMPARATOR
Intervention: Gelatin Sponge
Number of subjects: 40
Study 23276715 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 kV
Number of subjects: 60
Study 22388884 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 15 mg daily
Number of subjects: 366
Study 22388884 — intervention group
Group type: COMPARATOR
Intervention: Gefarnate 50 mg twice daily
Number of subjects: 366
Study 19908928 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertapenem
Number of subjects: 0
Study 19908928 — intervention group
Group type: COMPARATOR
Intervention: Piperacillin/tazobactam
Number of subjects: 0
Study 17786079 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg
Number of subjects: 0
Study 17786079 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 0
Study 17786079 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15177521 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine besylate/benazepril HCl combination therapy (5/20 mg/d titrated to 10/20 mg/d)
Number of subjects: 364
Study 15177521 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine besylate/benazepril HCl combination therapy
Number of subjects: 364
Study 15177521 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine besylate monotherapy (5 mg/d titrated to 10 mg/d)
Number of subjects: 364
Study 15177521 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine besylate monotherapy
Number of subjects: 364
Study 11156753 — intervention group
Group type: EXPERIMENTAL
Intervention: Divalproex sodium
Number of subjects: 56
Study 11156753 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 9498468 — intervention group
Group type: EXPERIMENTAL
Intervention: ETEC/rCTB vaccine (E003)
Number of subjects: 74
Study 9498468 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 8002507 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training program (16 weeks)
Number of subjects: 22
Study 3264141 — intervention group
Group type: COMPARATOR
Intervention: Cardioplegic solution without allopurinol (Group 1)
Number of subjects: 14
Study 3264141 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardioplegic solution with 100 mg allopurinol (Group 2)
Number of subjects: 14
Study 30789807 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg of calcium and 800 IU vitamin D supplementation
Number of subjects: 151
Study 30789807 — intervention group
Group type: COMPARATOR
Intervention: Placebo group with neither calcium nor vitamin D supplementation
Number of subjects: 151
Study 30789807 — intervention group
Group type: EXPERIMENTAL
Intervention: Bat haplotype
Number of subjects: 151
Study 31124942 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Laryngoscopy (DL) first group
Number of subjects: 20
Study 31124942 — intervention group
Group type: COMPARATOR
Intervention: Video Laryngoscopy (VL) first group
Number of subjects: 20
Study 29018027 — intervention group
Group type: EXPERIMENTAL
Intervention: RDN plus SSAHT
Number of subjects: 106
Study 29018027 — intervention group
Group type: COMPARATOR
Intervention: SSAHT alone
Number of subjects: 106
Study 26691637 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline HRV
Number of subjects: 282